Market revenue in 2023 | USD 144.0 million |
Market revenue in 2030 | USD 205.0 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Endoscopes |
Fastest growing segment | Endoscopes |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI), Endoscopes, X-ray Fluoroscopy, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT) |
Key market players worldwide | Koninklijke Philips NV, Medtronic PLC, Siemens Healthineers AG ADR, Analogic Corporation, GE HealthCare Technologies Inc Common Stock, BrainLAB, Olympus Corp, Stryker Corp, Varian |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to image-guided therapy systems market will help companies and investors design strategic landscapes.
Endoscopes was the largest segment with a revenue share of 32.85% in 2023. Horizon Databook has segmented the France image-guided therapy systems market based on computed tomography (ct) scanners, ultrasound systems, magnetic resonance imaging (mri), endoscopes, x-ray fluoroscopy, positron emission tomography (pet), single photon emission computed tomography (spect) covering the revenue growth of each sub-segment from 2018 to 2030.
France is the second-largest medical device market in Europe. Its image-guided therapy systems market is driven by increase in geriatric population, growth in adoption of advanced technologies, and technological advancements that result in new product launches.
In June 2017, Accuray’s Radixact Treatment Delivery System was installed at University Cancer Institute of Toulouse Oncopole (IUCT Oncopole), France, to provide advanced radiation therapy to cancer patients.
Various research initiatives undertaken by the French National Cancer Institute (INCa) for advancing radiotherapy are expected to drive the market. For instance, in June 2017, French Cancer Institute announced its plans to develop its Re-irradiation and Adaptive Radiotherapy Program using Accuray’s Radixact Treatment Delivery System.
Horizon Databook provides a detailed overview of country-level data and insights on the France image-guided therapy systems market , including forecasts for subscribers. This country databook contains high-level insights into France image-guided therapy systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account